← Leaderboards
Mark A. Rubin
Brigham And Women'S Hospital
$21,732,421
Attributed
$31,352,054
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.7M · FY2005–21$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$33,537,053 · 12
By mechanism
R01$15,244,431 · 5
UG3$6,820,862 · 1
P50$5,056,660 · 3
U01$4,980,213 · 2
U24$1,434,887 · 1
Top collaborators
- Arul M Chinnaiyan6 shared
- Olivier Elemento3 shared
- Ali G Gharavi3 shared
- David B. Goldstein3 shared
- George M. Hripcsak3 shared
- Rainu Kaushal3 shared
- Daniel W Lin3 shared
- Margaret Elizabeth Ross3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Shumin Zhang$2,945,575
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateBaseMolecularSamplingGenomicsMalignant NeoplasmsCohortProstateTumorDiagnosisDisease ProgressionCessation Of LifeMichiganHeterogeneityGrantResearch PersonnelPublishingFollow-UpGenesMutationLeadCancer PatientEventBiopsy
Grant awards (58)
Project 3: Towards Understanding Prostate Cancer Heterogeneity$346,460
P50 · FY2021 · CA · contact PI
Administrative Core$211,231
P50 · FY2021 · CA · contact PI
Project 3: Towards Understanding Prostate Cancer Heterogeneity$353,910
P50 · FY2020 · CA · contact PI
Administrative Core$215,775
P50 · FY2020 · CA · contact PI
Project 3: Towards Understanding Prostate Cancer Heterogeneity$346,459
P50 · FY2019 · CA · contact PI
Administrative Core$211,230
P50 · FY2019 · CA · contact PI
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$472,504
U24 · FY2018 · CA
Project 3: Towards Understanding Prostate Cancer Heterogeneity$372,538
P50 · FY2018 · CA · contact PI
Administrative Core$227,128
P50 · FY2018 · CA · contact PI
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer$2,184,999
P50 · FY2017 · CA · contact PI
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPO$2,128,967
UG3 · FY2017 · OD
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$472,504
U24 · FY2017 · CA
Project 3: Towards Understanding Prostate Cancer Heterogeneity$371,556
P50 · FY2017 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$317,614
R01 · FY2017 · CA · contact PI
Administrative Core$215,374
P50 · FY2017 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$54,796
R01 · FY2017 · CA · contact PI
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPO$4,461,312
UG3 · FY2016 · OD
Precision Medicine Approach to Prostate Cancer Active Surveillance$695,027
R01 · FY2016 · CA · contact PI
The joint WCM-NYGC Center for Functional and Clinical Interpretation of Tumor Profiles$489,879
U24 · FY2016 · CA
Molecular Signatures of Lethal and Indolent Prostate Cancer$422,121
R01 · FY2016 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$373,464
R01 · FY2016 · CA · contact PI
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPO$230,583
UG3 · FY2016 · OD
Precision Medicine Approach to Prostate Cancer Active Surveillance$695,027
R01 · FY2015 · CA · contact PI
Molecular Signatures of Lethal and Indolent Prostate Cancer$593,829
R01 · FY2015 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$374,488
R01 · FY2015 · CA · contact PI
A Systems Biology Approach to the Development of Cancer Biomarkers$163,530
U01 · FY2015 · CA
Precision Medicine Approach to Prostate Cancer Active Surveillance$747,152
R01 · FY2014 · CA · contact PI
A Systems Biology Approach to the Development of Cancer Biomarkers$614,261
U01 · FY2014 · CA
Molecular Signatures of Lethal and Indolent Prostate Cancer$576,014
R01 · FY2014 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$366,367
R01 · FY2014 · CA · contact PI
A Systems Biology Approach to the Development of Cancer Biomarkers$634,323
U01 · FY2013 · CA
Molecular Signatures of Lethal and Indolent Prostate Cancer$558,199
R01 · FY2013 · CA · contact PI
Comprehensive Prostate Cancer Characterization by Genomic and Transcriptomic Prof$557,532
R01 · FY2013 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$408,737
R01 · FY2013 · CA · contact PI
A Systems Biology Approach to the Development of Cancer Biomarkers$685,047
U01 · FY2012 · CA
Comprehensive Prostate Cancer Characterization by Genomic and Transcriptomic Prof$593,977
R01 · FY2012 · CA · contact PI
Molecular Signatures of Lethal and Indolent Prostate Cancer$593,829
R01 · FY2012 · CA · contact PI
A Systems Biology Approach to the Development of Cancer Biomarkers$695,128
U01 · FY2011 · CA
Comprehensive Prostate Cancer Characterization by Genomic and Transcriptomic Prof$612,154
R01 · FY2011 · CA · contact PI
A Systems Biology Approach to the Development of Cancer Biomarkers$703,683
U01 · FY2010 · CA
"Molecular Signatures of Lethal and Indolent Prostate Cancer"$524,925
R01 · FY2010 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$365,372
R01 · FY2010 · CA · contact PI
"Molecular Signatures of Lethal and Indolent Prostate Cancer"$514,171
R01 · FY2009 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$365,372
R01 · FY2009 · CA · contact PI
"Molecular Signatures of Lethal and Indolent Prostate Cancer"$532,731
R01 · FY2008 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$365,314
R01 · FY2008 · CA · contact PI
"Molecular Signatures of Lethal and Indolent Prostate Cancer"$508,718
R01 · FY2007 · CA · contact PI
Towards Understanding Prostate Cancer Heterogeneity$389,543
R01 · FY2007 · CA · contact PI
"Molecular Signatures of Lethal and Indolent Prostate Cancer"$510,769
R01 · FY2006 · CA · contact PI
Prostate Cancer Harbinger Genes$509,402
R01 · FY2006 · AG · contact PI
Prostate Cancer Harbinger Genes$521,660
R01 · FY2005 · AG
Prostate Cancer Harbinger Genes$537,464
R01 · FY2004 · AG
Molecular Dissection of Benign Prostatic Hyperplasia$496,922
U01 · FY2004 · AG
Prostate Cancer Harbinger Genes$15,343
R01 · FY2004 · AG
Prostate Cancer Harbinger Genes$521,660
R01 · FY2003 · AG
Molecular Dissection of Benign Prostatic Hyperplasia$497,753
U01 · FY2003 · AG
Prostate Cancer Harbinger Genes$521,660
R01 · FY2002 · AG
Molecular Dissection of Benign Prostatic Hyperplasia$489,566
U01 · FY2002 · AG